BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants

Benzer Materyaller

• Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor
  Yazar:: Timmers, Maarten, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
  Yazar:: Novak, Gerald, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors
  Yazar:: Van Broeck, Bianca, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
  Yazar:: Timmers, Maarten, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo.
  Yazar:: Zhou, Lujia, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)